CA2533833C - Oral delivery system comprising a biliquid foam - Google Patents

Oral delivery system comprising a biliquid foam Download PDF

Info

Publication number
CA2533833C
CA2533833C CA2533833A CA2533833A CA2533833C CA 2533833 C CA2533833 C CA 2533833C CA 2533833 A CA2533833 A CA 2533833A CA 2533833 A CA2533833 A CA 2533833A CA 2533833 C CA2533833 C CA 2533833C
Authority
CA
Canada
Prior art keywords
delivery system
drug delivery
oral drug
agent
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2533833A
Other languages
English (en)
French (fr)
Other versions
CA2533833A1 (en
Inventor
William Charman
Monica Dias
Michelle Georgiou
Philip Guffogg
Christopher Porter
Colin Pouton
Fraser Steele
Derek Wheeler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MC2 Therapeutics Ltd
Original Assignee
Drug Delivery Solutions Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drug Delivery Solutions Ltd filed Critical Drug Delivery Solutions Ltd
Publication of CA2533833A1 publication Critical patent/CA2533833A1/en
Application granted granted Critical
Publication of CA2533833C publication Critical patent/CA2533833C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
CA2533833A 2003-07-30 2004-07-30 Oral delivery system comprising a biliquid foam Expired - Lifetime CA2533833C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0317869.6 2003-07-30
GBGB0317869.6A GB0317869D0 (en) 2003-07-30 2003-07-30 Improved drug delivery system
PCT/GB2004/003329 WO2005011628A2 (en) 2003-07-30 2004-07-30 Oral delivery system comprising a biliquid foam

Publications (2)

Publication Number Publication Date
CA2533833A1 CA2533833A1 (en) 2005-02-10
CA2533833C true CA2533833C (en) 2013-05-28

Family

ID=27799499

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2533833A Expired - Lifetime CA2533833C (en) 2003-07-30 2004-07-30 Oral delivery system comprising a biliquid foam

Country Status (14)

Country Link
US (1) US20060228408A1 (https=)
EP (1) EP1653923B1 (https=)
JP (1) JP4953815B2 (https=)
CN (2) CN1832727A (https=)
AT (1) ATE465715T1 (https=)
AU (1) AU2004261053B2 (https=)
CA (1) CA2533833C (https=)
DE (1) DE602004026879D1 (https=)
DK (1) DK1653923T3 (https=)
ES (1) ES2344898T3 (https=)
GB (1) GB0317869D0 (https=)
RU (1) RU2353350C2 (https=)
WO (1) WO2005011628A2 (https=)
ZA (1) ZA200600761B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0404403D0 (en) 2004-02-27 2004-03-31 Disperse Ltd Dispersions
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP2008651A1 (en) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
GB0712389D0 (en) * 2007-06-26 2007-08-01 Drug Delivery Solutions Ltd A Pharmaceutical composition
CN101780037B (zh) * 2010-02-03 2011-11-16 南昌大学 双嘧达莫自乳化给药系统及其制备方法
GB201006218D0 (en) 2010-04-14 2010-06-02 Ayanda As Composition
HRP20191711T1 (hr) 2011-03-14 2019-12-13 Drug Delivery Solutions Ltd Oftalmološki pripravak
EP2696846B1 (en) * 2011-04-11 2018-01-17 Vitux Group AS Oral pharmaceutical dispersion compositions
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486333A (en) * 1981-04-10 1984-12-04 Felix Sebba Preparation of biliquid foam compositions
US4999198A (en) * 1989-03-23 1991-03-12 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Polyaphrons as a drug delivery system
IL105553A (en) * 1992-05-06 1998-01-04 Janssen Pharmaceutica Inc Solid dosage form comprising a porous network of matrix forming material which disperses rapidly in water
US5840881A (en) * 1992-11-27 1998-11-24 Takeda Chemical Industries, Ltd. Composition containing a water-insoluble or slightly water-soluble compound with enhanced water-solubility
CN1138515C (zh) * 1996-03-08 2004-02-18 迪斯珀斯有限公司 包含一种油基双液体泡沫和一种水凝胶的分散体系
NL1003503C2 (nl) * 1996-07-04 1998-01-07 Negma Steba International Dev Farmaceutische samenstelling voor orale toediening.
GB2326337A (en) * 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
CN1362873A (zh) * 2000-02-22 2002-08-07 彩色通路公司 胶凝的水溶液美容组合物
GB0214793D0 (en) * 2002-06-26 2002-08-07 Disperse Technologies Plc Biliquid foam entrapment

Also Published As

Publication number Publication date
CN101579311A (zh) 2009-11-18
WO2005011628A2 (en) 2005-02-10
AU2004261053A1 (en) 2005-02-10
DE602004026879D1 (de) 2010-06-10
CA2533833A1 (en) 2005-02-10
ZA200600761B (en) 2007-05-30
EP1653923B1 (en) 2010-04-28
RU2353350C2 (ru) 2009-04-27
AU2004261053B2 (en) 2011-08-25
ES2344898T3 (es) 2010-09-09
ATE465715T1 (de) 2010-05-15
RU2006106173A (ru) 2007-09-10
JP2007500181A (ja) 2007-01-11
JP4953815B2 (ja) 2012-06-13
EP1653923A2 (en) 2006-05-10
US20060228408A1 (en) 2006-10-12
GB0317869D0 (en) 2003-09-03
CN101579311B (zh) 2013-11-27
WO2005011628A3 (en) 2005-05-06
CN1832727A (zh) 2006-09-13
DK1653923T3 (da) 2010-08-09

Similar Documents

Publication Publication Date Title
KR101382725B1 (ko) 소수성 약물의 약물전달시스템 및 이를 포함하는 조성물
EP0750495B1 (en) Use of a lipophilic surfactant in a pharmaceutical composition
JP2002537317A (ja) 疎水性治療剤の改善された送達のための組成物および方法
EP2008651A1 (en) A bioerodible patch
WO2009001099A2 (en) A pharmaceutical composition
CA2533833C (en) Oral delivery system comprising a biliquid foam
CA2443461A1 (en) Pharmaceutical formulations containing anti-inflammatory active ingredients and the use of said formulations

Legal Events

Date Code Title Description
EEER Examination request
H11 Ip right ceased following rejected request for revival

Free format text: ST27 STATUS EVENT CODE: T-6-6-H10-H11-H101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TIME LIMIT FOR REVERSAL EXPIRED

Effective date: 20250131